Health Care/Hospital
Conbercept: New Generation of Product for Treatment of nAMD Completes 36-week Primary Endpoint Visits of Phase III Trial
CHENGDU, China, Dec. 23, 2020 /PRNewswire/ -- Chengdu Kanghong Pharmaceutical Group ("Kanghong") announced a key development milestone of its key product conbercept last month. Kanghong is seeking global approval of conbercept by undertaking a multicenter, multinational, double-masked, parallel-gr...
2020-12-23 22:40
5984
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement
HANGZHOU, China, Dec. 23, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it h...
2020-12-23 21:30
16188
I-Mab Announces Upcoming Participation at January Conferences
SHANGHAI and GAITHERSBURG, Md., Dec. 23, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in Januar...
2020-12-23 21:00
5627
AI Proves Its Value in Assistance for Emergency Cases - With Higher Accuracy and Timely Reporting Time of Chest Radiographs
SEOUL, South Korea, Dec. 23, 2020 /PRNewswire/ -- A study conducted by Seoul National University Hospital, one of the most renowned medical institutes in Asia, has revealed that an AI can help radiologists improve their performance and reduce reporting time for critical or urgent cases. The study...
2020-12-23 19:53
1522
Thailand continues to reopen for travellers slowly and safely
BANGKOK, Dec. 23, 2020 /PRNewswire/ -- Thailand's tourism sector continues to safely and slowly reopen welcoming international travellers to the country with special tourist initiatives, while also remaining vigilant by enforcing strict public health guidelines to protect all during the ongoing C...
2020-12-23 15:53
2642
Innovent Announces NMPA Granted New Indication Approvals for SULINNO® (Adalimumab Injection) for the Treatment of Pediatric Plaque Psoriasis and Non-infectious Uveitis
SAN FRANCISCO and SUZHOU, China, Dec. 23, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2020-12-23 12:30
8490
Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19
SEOUL, South Korea, Dec. 22, 2020 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ symbol: 048410) announced on the 23rd, December 2020, that CNPharm, its major shareholding bio tech company, has succeeded in developing 'Poly-COV01,' an injection drug for thepotential treatment of patients with severe ...
2020-12-23 10:09
1485
2020 Responsibilities for Health Forum co-organized by Infinitus held in Beijing
GUANGZHOU, China, Dec. 23, 2020 /PRNewswire/ -- On December 16, co-hosted by the China Association of Chinese Medicine (CACM) and Health.People.cn, and co-organized by Infinitus (China) Company Ltd. (Infinitus (China)), the 2020 Responsibilities for Health Forum and the launch conference of theCh...
2020-12-23 08:30
283
Transcenta Closes $105 Million in Crossover Financing
HONG KONG and SUZHOU, China, and HANGZHOU, China, Dec. 23, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces today the complet...
2020-12-23 08:00
3748
Irish Technology deployed in South Africa as part of International Music Events re-opening
DUBLIN, Dec. 23, 2020 /PRNewswire/ -- Irish-based Health Passport Europe has partnered with Big Concerts and The Entertainment Group to safely re-open the events industry inSouth Africa, using latest developments in rapid COVID-19 testing and the secure Health Passport Europe mobile technology. ...
2020-12-23 03:15
3374
RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue
Independent DSMB unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 based on review of unblinded safety data from 155 treated patients Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021 Top-line d...
2020-12-22 20:38
4215
Origin Agritech Comments on Recent Regulatory Developments in China and Updates Shareholders on its Pipeline of Traits
BEIJING, Dec. 22, 2020 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, today is updating shareholders on recent developments out ofChina regarding the path to GMO commercialization in the country and also on the status of the app...
2020-12-22 20:30
5181
Overweight and Obese Subjects Dosed with ASC41 Tablets in a Phase Ib Trial
SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announces today dosing of overweight and obese subjects in a Phase Ib trial of ASC41, an oral tablet,...
2020-12-22 19:18
2768
Ascentage Pharma's Licensee UNITY Biotechnology Announces Milestone Reached in Clinical Development of Treatments for Age-Related Disease, Leading to Milestone Payment
SUZHOU, China and ROCKVILLE, Md., Dec. 22, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its licensee, UNITY Bi...
2020-12-22 18:29
1670
111, Inc. Announces Additional Round of New Capital Injection
SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced the successful completion of new capital injection in it...
2020-12-22 17:22
11706
Leapstack has completed tens of millions of yuan in B plus round fundraising, expending intelligent risk control territory
SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- Leapstack, an insur-tech company, has recently announcedtens of millions of yuan B plus round fundraising, leading by Huazhi Capital, a venture capitalist affiliated toAllinpay Network Services, and following by GF Securities Investment. In the past few ye...
2020-12-22 15:50
4390
Alterity and UniQuest partner to reverse bacterial resistance to antibiotics
MELBOURNE, Australia, Dec. 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced it has been granted a licence by UniQuest, the commercialisation company of The University of Queensland (UQ), to novel zinc ionophore technology to ...
2020-12-22 05:42
5546
Home is Where the Heart is for Students, GSA Reveals
Global poll reveals what students really crave this Christmas MELBOURNE, Australia, Dec. 22, 2020 /PRNewswire/ -- 2020 is set to be a festive season like no other, but new research* released today has shown that some things never change, as all students really want is a roast dinner and quality...
2020-12-22 05:00
2448
DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd
PARK CITY, Utah, Dec. 22, 2020 /PRNewswire/ -- DW Healthcare Partners V, L.P. ("Purchaser"), announced today that it has commenced a cash tender offer for all of the outstanding ordinary shares of Parnell Pharmaceuticals Holdings Ltd (OTC Pink Open Market: PARNF) ("Parnell") at a price of U.S.$0....
2020-12-21 23:07
13734
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004
SEATTLE, Dec. 21, 2020 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced its partnership with Laboratoire Pierre Fabre to manufacture ER-004 – an intra-amniotic drug that will pioneer the treatment of a rare and...
2020-12-21 23:00
1435
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 318 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 295 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 288 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 253 media titles]
2024-04-30 15:13Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
11906
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
7678
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
7539
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
7221
